과제정보
This study was supported by the National Research Foundation of Korea (NRF) funded by the Korean government (Grant no. NRF-2022R1F1A1072273).
참고문헌
- Mukund K, Subramaniam S. Skeletal muscle: a review of molecular structure and function, in health and disease. Wiley Interdiscip Rev Syst Biol Med. 2020;12:e1462.
- Chal J, Pourquie O. Making muscle: skeletal myogenesis in vivo and in vitro. Development. 2017;144:2104-2122. https://doi.org/10.1242/dev.151035
- Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun. 2021;12:330.
- Akhmedov D, Berdeaux R. The effects of obesity on skeletal muscle regeneration. Front Physiol. 2013;4:371.
- Guerin CM, Kramer SG. Cytoskeletal remodeling during myotube assembly and guidance: coordinating the actin and microtubule networks. Commun Integr Biol. 2009;2:452-457. https://doi.org/10.4161/cib.2.5.9158
- Heng YW, Koh CG. Actin cytoskeleton dynamics and the cell division cycle. Int J Biochem Cell Biol. 2010;42:1622-1633. https://doi.org/10.1016/j.biocel.2010.04.007
- Watt KI, Goodman CA, Hornberger TA, Gregorevic P. The Hippo signaling pathway in the regulation of skeletal muscle mass and function. Exerc Sport Sci Rev. 2018;46:92-96. https://doi.org/10.1249/JES.0000000000000142
- Fischer M, Rikeit P, Knaus P, Coirault C. YAP-mediated mechanotransduction in skeletal muscle. Front Physiol. 2016;7:41.
- Nguyen NU, Liang VR, Wang HV. Actin-associated protein palladin is required for migration behavior and differentiation potential of C2C12 myoblast cells. Biochem Biophys Res Commun. 2014;452:728-733. https://doi.org/10.1016/j.bbrc.2014.08.143
- Li H, Hou L, Zhang Y, Jiang F, Zhu Y, Li QX, Hu CY, Wang C. PFN2a suppresses C2C12 myogenic development by inhibiting proliferation and promoting apoptosis via the p53 pathway. Cells. 2019;8:959.
- Nguyen MT, Min KH, Kim D, Park SY, Lee W. CFL2 is an essential mediator for myogenic differentiation in C2C12 myoblasts. Biochem Biophys Res Commun. 2020;533:710-716. https://doi.org/10.1016/j.bbrc.2020.11.016
- Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179-183. https://doi.org/10.1038/nature10137
- Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013;154:1047-1059. https://doi.org/10.1016/j.cell.2013.07.042
- Nguyen MT, Won YH, Kwon TW, Lee W. Twinfilin-1 is an essential regulator of myogenic differentiation through the modulation of YAP in C2C12 myoblasts. Biochem Biophys Res Commun. 2022;599:17-23. https://doi.org/10.1016/j.bbrc.2022.02.021
- Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451-5465. https://doi.org/10.1002/jcp.27486
- Dowling L, Duseja A, Vilaca T, Walsh JS, Goljanek-Whysall K. MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review. J Cachexia Sarcopenia Muscle. 2022;13:68-85. https://doi.org/10.1002/jcsm.12878
- Zhao Y, Chen M, Lian D, Li Y, Li Y, Wang J, Deng S, Yu K, Lian Z. Non-coding RNA regulates the myogenesis of skeletal muscle satellite cells, injury repair and diseases. Cells. 2019;8:988.
- Sannicandro AJ, Soriano-Arroquia A, Goljanek-Whysall K. Micro(RNA)-managing muscle wasting. J Appl Physiol (1985). 2019;127:619-632. Erratum in: J Appl Physiol (1985). 2019;127:1502.
- Ji C, Guo X. The clinical potential of circulating microRNAs in obesity. Nat Rev Endocrinol. 2019;15:731-743. https://doi.org/10.1038/s41574-019-0260-0
- Xia W, Ni J, Zhuang J, Qian L, Wang P, Wang J. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12. Int J Biochem Cell Biol. 2016;71:1-11. https://doi.org/10.1016/j.biocel.2015.11.017
- Correction: miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2017;77:6788. Erratum for: Cancer Res. 2012;72:3631-3641. https://doi.org/10.1158/0008-5472.CAN-12-0667
- Li K, Yuan C. MicroRNA-103 modulates tumor progression by targeting KLF7 in non-small cell lung cancer. Int J Mol Med. 2020;46:1013-1028. https://doi.org/10.3892/ijmm.2020.4649
- Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011;474:649-653. https://doi.org/10.1038/nature10112
- Naar AM. MiRs with a sweet tooth. Cell Metab. 2011;14:149-150. https://doi.org/10.1016/j.cmet.2011.07.005
- Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239-250. Erratum in: Nat Rev Mol Cell Biol. 2012;13:1.
- Cui X, You L, Zhu L, Wang X, Zhou Y, Li Y, Wen J, Xia Y, Wang X, Ji C, Guo X. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes. Metabolism. 2018;78:95-105. https://doi.org/10.1016/j.metabol.2017.09.006
- Xu Q, Li Y, Shang YF, Wang HL, Yao MX. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. World J Gastroenterol. 2015;21:511-516. https://doi.org/10.3748/wjg.v21.i2.511
- Yamamoto H, Morino K, Nishio Y, Ugi S, Yoshizaki T, Kashiwagi A, Maegawa H. MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial transcription factor A and Forkhead box j3. Am J Physiol Endocrinol Metab. 2012;303:E1419-E1427. https://doi.org/10.1152/ajpendo.00097.2012
- Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011;1807:726-734. https://doi.org/10.1016/j.bbabio.2010.10.022
- Nguyen MT, Min KH, Lee W. MiR-96-5p induced by palmitic acid suppresses the myogenic differentiation of C2C12 myoblasts by targeting FHL1. Int J Mol Sci. 2020;21:9445.
- Dupont S. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction. Exp Cell Res. 2016;343:42-53. https://doi.org/10.1016/j.yexcr.2015.10.034
- Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer. 2006;6:99-106. https://doi.org/10.1038/nrc1802
- Mok GF, Lozano-Velasco E, Munsterberg A. microRNAs in skeletal muscle development. Semin Cell Dev Biol. 2017;72:67-76. https://doi.org/10.1016/j.semcdb.2017.10.032
- Poukkula M, Kremneva E, Serlachius M, Lappalainen P. Actin-depolymerizing factor homology domain: a conserved fold performing diverse roles in cytoskeletal dynamics. Cytoskeleton (Hoboken). 2011;68:471-490. https://doi.org/10.1002/cm.20530
- Palmgren S, Vartiainen M, Lappalainen P. Twinfilin, a molecular mailman for actin monomers. J Cell Sci. 2002;115(Pt 5):881-886. https://doi.org/10.1242/jcs.115.5.881
- Johnston AB, Collins A, Goode BL. High-speed depolymerization at actin filament ends jointly catalysed by Twinfilin and Srv2/CAP. Nat Cell Biol. 2015;17:1504-1511. https://doi.org/10.1038/ncb3252
- Hakala M, Wioland H, Tolonen M, Kotila T, Jegou A, Romet-Lemonne G, Lappalainen P. Twinfilin uncaps filament barbed ends to promote turnover of lamellipodial actin networks. Nat Cell Biol. 2021;23:147-159. Erratum in: Nat Cell Biol. 2021;23:437-438. https://doi.org/10.1038/s41556-021-00651-8
- Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 2009;58:1050-1057. https://doi.org/10.2337/db08-1299
- Mendez MG, Janmey PA. Transcription factor regulation by mechanical stress. Int J Biochem Cell Biol. 2012;44:728-732. https://doi.org/10.1016/j.biocel.2012.02.003
- Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491-505. https://doi.org/10.1016/j.devcel.2010.09.011